Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women".
Vivencio
V
Barrios
Carlos
C
Escobar
Rocio
R
Echarri
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000453:epidemiology* / Q000503:physiopathology; D001794:Blood Pressure; D015331:Cohort Studies; D003971:Diastole; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000453:epidemiology* / Q000503:physiopathology / Q000517:prevention & control*; D015994:Incidence; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012307:Risk Factors; D013599:Systole; D014810:Vitamin E / Q000627:therapeutic use*
D000975:Antioxidants; D010975:Platelet Aggregation Inhibitors; D014810:Vitamin E; D001241:Aspirin